Results 291 to 300 of about 11,978,501 (365)

Targeting gut microbiota in liver disease: A pharmacological approach for hepatic encephalopathy and beyond. [PDF]

World J Gastrointest Pharmacol Ther
Vargas-Beltran AM, Mialma-Omana SJ, Vivanco-Tellez DO.   +2 more
europepmc   +1 more source

Physician Referral Patterns to Physical Therapists for Managing Knee Osteoarthritis: A Retrospective Analysis of Electronic Health Records from an Integrated Health System

Arthritis Care &Research, Accepted Article.
Objectives This study aims to describe the frequency and timing of physician referrals to physical therapists (PT) and other treatments prescribed over 12 months in patients with recent onset of knee osteoarthritis (KOA). The study also aims to identify determinants of early PT referrals.
Samannaaz S. Khoja, Joel M. Stevans, Gustavo J. Almeida, Clair Smith, Janet K. Freburger   +4 more
wiley   +1 more source

The pathophysiological role of portal hypertension in metabolic dysfunction-associated steatotic liver disease. [PDF]

Hepatol Commun
Møller S, Sjöstedt SMS, Hobolth L, Mortensen C, Mortensen C, Kimer N.   +5 more
europepmc   +1 more source

Identifying High‐Impact Solutions to Address Racial and Ethnic Health Disparities in Lupus: A Consensus‐Based Approach

Arthritis Care &Research, EarlyView.
Objective We conducted formative research aimed at identifying solutions that address inequitable health outcomes in lupus due to adverse social determinants of health (SDoH). Methods We conducted a search for keywords, which provided insights into potential solutions and initiatives underway. An advisory panel of lupus experts iteratively reviewed the
Joy Buie, Michael P. Fisher, Kristen Backor, Hannah Tyldsley, Ashira Blazer, Candace Feldman, Andrea Knight, S. Sam Lim, Barbara Ann Polk, Ed Yelin, Edith Williams, Karen H. Costenbader   +11 more
wiley   +1 more source

Metabolic dysfunction‑associated steatotic liver disease: Pathogenesis, model and treatment (Review). [PDF]

Int J Mol Med
Ma Q, Liu K, Chang C, Wang L, Shen Z, Li J, Adu M, Lin Q, Huang H, Wu X, Wei R.   +10 more
europepmc   +1 more source

Considerations for Issues of Regression to the Mean and Contextual Effects in Clinical Trials for Pain in Rheumatic Diseases

Arthritis Care &Research, EarlyView.
Recently, there has been growing discussion about how to best assess pain in clinical trials in rheumatic diseases. Reliable measurement of pain outcomes is essential for accurately determining the effectiveness of treatments. Although pain intensity is the most common measure of change in pain trials, other pain‐related measures, such as pain ...
Yen T. Chen, Guohao Zhu, Afton L. Hassett, Daniel Clauw, Susan L. Murphy   +4 more
wiley   +1 more source

Association between ABO blood group system and autoimmune liver disease. [PDF]

Front Med (Lausanne)
Hong Y, Mu S, Wang L.
europepmc   +1 more source

Mesenchymal stem cell therapy for end-stage liver disease: adversity and opportunity. [PDF]

Stem Cell Res Ther
Li S, Wang Y, Li SM, Zhu Y, Du YQ, Zheng X, Wu J.   +6 more
europepmc   +1 more source

Metabolic Dysfunction-Associated Steatotic Liver Disease in a Patient with Phelan-McDermid Syndrome. [PDF]

Life (Basel)
Boccuto L, Scarlata GGM, Moffitt BA, Sarasua SM, Phelan K, Rogers C, Abenavoli L.   +6 more
europepmc   +1 more source

Comparative Study of DTMUV and LPS on Duck Liver Disease. [PDF]

Vet Sci
Lan Z, Sun Z, Wang Y, Li H, Sun X.
europepmc   +1 more source